Technologieangebote

Inhibition of micro RNA maturation as new drug target

A technology which uses Micro RNA (miRNA) inhibition for the treatment of diseases is offered. MiRNA maturation is inhibited by a specifically reduced dicer activity. Thus miRNA production is reduced and consequently the pathogenic impact.

Weitere Informationen: PDF

ipal GmbH
Tel.: +49 (0)30/2125-4820

Ansprechpartner
Ursula Haufe

Kommentare (0)

Schreiben Sie einen Kommentar